1-6 of 262 Activities
In this CME Outfitters live Q&A, expert faculty will answer questions about the multifaceted impact of GLP-1 RA therapies on glycemic control, CV health, weight management, renal health, liver health, and overall T2D complication risk.
In this CME Outfitters livestream symposium, expert faculty will guide learners on the implementation of routine HIV testing and on adopting a status-neutral approach to effectively promote prevention strategies and PrEP initiation. Faculty will evaluate current and emerging PrEP options, introduce emerging LAI PrEP options, and discuss optimal patient selection criteria, transitioning strategies, and monitoring considerations. Faculty will model integration of effective patient engagement strategies to collaboratively initiate PrEP treatment and support adherence.
In this CME Outfitters live webcast, expert faculty will examine socioeconomic, geographic, and systemic factors that contribute to disparities in clinical trial access, particularly in underserved or community-based settings. Faculty will help learners identify interprofessional strategies, including use of culturally responsive communication, patient navigators, and advocacy partnerships, to engage underrepresented patients in clinical trial discussions and enrollment.
In this CME Outfitters Webcast, expert faculty will discuss strategies for identifying the physiologic biopsychosocial factors that influence pain, utilizing pain assessment tools that reinforce approaches to the appropriate management of pain, implementing strategies from the 2022 CDC Guideline for Prescribing Opioids into the development of safe and effective pain management plans, and other valuable skills for improving the treatment of patients suffering from chronic pain.
In the fourth activity of this CME Outfitters Snack series, expert faculty will individualize the selection of GLP-1 RA therapies based on patient-specific factors such as CV risk, weight management needs, and preferences for administration.
In this CME Outfitters recorded webcast, expert faculty will discuss the latest evidence on the teratogenic risks of mycophenolate; share strategies for counseling patients before and during mycophenolate administration on appropriate pregnancy testing and acceptable contraception methods; and examine the critical role of the Mycophenolate Pregnancy Registry in supporting ongoing pharmacovigilance in confirmed pregnancies.
